Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Walker & Dunlop Arranges $40 Million Debt and Equity for Seniors Property in Maryland (Business Wire) +++ FREDDIE MAC Aktie +3,23%

EUROFINS Aktie

 >EUROFINS Aktienkurs 
59.1 EUR    -7.3%    (Tradegate)
Ask: 59.1 EUR / 1000 Stück
Bid: 59.02 EUR / 1000 Stück
Tagesumsatz: 3885 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
EUROFINS Aktie über LYNX handeln
>EUROFINS Performance
1 Woche: +3,7%
1 Monat: +1,7%
3 Monate: +4,1%
6 Monate: +28,3%
1 Jahr: +13,2%
laufendes Jahr: +30,2%
>EUROFINS Aktie
Name:  EUROFINS SCIENTIFIC SE
Land:  Frankreich
Sektor:  Gesundheit
ISIN/ Wkn:  FR0014000MR3 / A2QJCT
Symbol/ Ticker:  ESF0 (Frankfurt)
Kürzel:  FRA:ESF0, ETR:ESF0, ESF0:GR
Index:  CAC40
Webseite:  https://www.eurofins.com/
Profil:  Eurofins Scientific SE is a global leader in bioan..
>Volltext..
Marktkapitalisierung:  11665.26 Mio. EUR
Unternehmenswert:  16277.97 Mio. EUR
Umsatz:  7243.8 Mio. EUR
EBITDA:  1498.79 Mio. EUR
Nettogewinn:  438.32 Mio. EUR
Gewinn je Aktie:  2.38 EUR
Schulden:  5393.79 Mio. EUR
Liquide Mittel:  585.34 Mio. EUR
Operativer Cashflow:  1231.92 Mio. EUR
Bargeldquote:  0.36
Umsatzwachstum:  6.25%
Gewinnwachstum:  13.91%
Dividende je Aktie:  0.6 EUR
Dividendenrendite:  0.94%
Dividendenschätzung:  0.94%
Div. Historie:  28.04.25 - 0.6€
03.07.24 - 0.5€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  EUROFINS
Letzte Datenerhebung:  21.10.25
>EUROFINS Kennzahlen
Aktien/ Unternehmen:
Aktien: 177.9 Mio. St.
Frei handelbar: 63.86%
Rückkaufquote: 2.65%
Mitarbeiter: 62696
Umsatz/Mitarb.: 0.1 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 7.98%
Bewertung:
KGV: 26.08
KGV lG: 17.47
KUV: 1.66
KBV: 3.07
PEG-Ratio: 1.61
EV/EBITDA: 10.86
Rentabilität:
Bruttomarge: 10.63%
Gewinnmarge: 6.05%
Operative Marge: 10.63%
Managementeffizenz:
Gesamtkaprendite: 4.04%
Eigenkaprendite: 11.27%
 >EUROFINS Anleihen 
Es sind 6 Anleihen zur EUROFINS Aktie bekannt.
>EUROFINS Peer Group

Es sind 70 Aktien bekannt.
 
21.10.25 - 10:36
Eurofins stock slides as Biopharma weakness tempers steady Q3; outlook kept (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.25 - 08:12
Eurofins Q3 Revenues Up 4.6%; Confirms Objectives For FY25 And FY27 (AFX)
 
PARIS (dpa-AFX) - Eurofins reported that its total revenues for the third quarter rose 4.6% to 1.803 billion euros from 1.723 billion euros last year. Quarterly organic revenue growth was 4.1%.Org......
21.10.25 - 07:18
4.0% Organic Revenue Growth in 9M 2025; Eurofins on Track for Solid Full Year Growth and Margin Expansion (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: The Eurofins (Paris:ERF) network of companies delivered steady improvement in organic revenue growth during the first nine months of 2025: Reported revenues in 9M 2025 totalled €5,415m, an increase of 5.3% vs 9M 2024. This was driven by organic growth13 and acquisitions, and was despite a -1.5% headwind from foreign exchange as the Euro strengthened against most currencies, and also one fewer public working day than in 9M 2024. Organic revenue growth13 in 9M 2025 was 4.0%, which includes an adjustment for public working days of 0.7%; In Europe, organic growth13 of 3.5% (2.7% excluding public working days) was led by Food & Feed and Environment Testing, with improved growth in Clinical Diagnostics in the third quarter. In North America, organic growth13 of 3.5% (2.9% excluding public working days) reflected further strengthening of Food, Feed and Environment testing, while end-market demand for Genomics and Ancillary activities within BioPharma Services remai...
21.10.25 - 06:12
TAGESVORSCHAU: Termine am 21. Oktober 2025 (DPA-AFX)
 
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Dienstag, den 21. Oktober 2025^TERMINE UNTERNEHMEN00:30 AUS: BHP Group, Q3 Operation Report07:00 SWE: Tele2, Q3-Zahlen07:00 LUX: Eurofins Scientific, Q3-Umsatz09:00 ......
20.10.25 - 17:48
Eurofins: Weekly Report on Share Repurchases From 13th October to 17th October 2025 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/10/2025 FR0014000MR3 10 000 61.6609 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 14/10/2025 FR0014000MR3 10 000 61.7272 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 15/10/2025 FR0014000MR3 10 000 62.0699 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 16/10/2025 FR0014000MR3 10 000 62.4281 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 17/10/2025 FR0014000MR3 10 000 62.4329 XPAR       TOTAL 50 000 62.0638   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes Contacts ...
20.10.25 - 17:42
TAGESVORSCHAU: Termine am 21. Oktober 2025 (DPA-AFX)
 
FRANKFURT (dpa-AFX) - Wirtschafts- und Finanztermine am Dienstag, den 21. Oktober 2025^TERMINE UNTERNEHMEN00:30 AUS: BHP Group, Q3 Operation Report07:00 SWE: Tele2, Q3-Zahlen07:00 LUX: Eurofins Scientific, Q3-Umsatz09:00 ......
15.10.25 - 16:54
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529...
13.10.25 - 17:48
Eurofins Scientific SE: Weekly Report on Share Repurchases from 06th October to 10th October 2025 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 06/10/2025 FR0014000MR3 10 000 62.2576 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 07/10/2025 FR0014000MR3 10 000 62.1582 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 08/10/2025 FR0014000MR3 10 000 62.2099 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 09/10/2025 FR0014000MR3 10 000 62.6027 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/10/2025 FR0014000MR3 10 000 62.7664 XPAR       TOTAL 50 000 62.3990   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-progra...
09.10.25 - 13:48
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Va Fleuri, L-1526 Luxembourg   2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial   3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEH...
06.10.25 - 17:51
Eurofins: Weekly Report on Share Repurchases From 29th September to 03rd October 2025 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 29/09/2025 FR0014000MR3 10 000 61.4364 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 30/09/2025 FR0014000MR3 10 000 60.8878 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/01/2025 FR0014000MR3 10 000 62.8008 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/02/2025 FR0014000MR3 10 000 63.0048 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/03/2025 FR0014000MR3 10 000 62.8917 XPAR       TOTAL 50 000 62.2043   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes Contacts ...
03.10.25 - 12:54
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S...
29.09.25 - 17:51
Eurofins: Weekly Report on Share Repurchases From 22nd September to 26th September 2025 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 22/09/2025 FR0014000MR3 10 000 62.5592 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 23/09/2025 FR0014000MR3 10 000 62.5362 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 24/09/2025 FR0014000MR3 10 000 62.0072 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/09/2025 FR0014000MR3 10 000 60.9076 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/09/2025 FR0014000MR3 10 000 61.1093 XPAR       TOTAL 50 000 61.8239   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes Contacts ...
29.09.25 - 15:00
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DY...
24.09.25 - 13:45
Eurofins Scientific SE: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharging managerial responsibilities/person closely associated a) Name VIGNEAU François   2. Reason for the notification a) Position / status Senior Vice President b) Initial notification / amendment Initial   3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529900JEHFM47DYY3S57   4. Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) ea...
23.09.25 - 15:54
Eurofins Scientific: Director/PDMR Shareholding (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the person discharging managerial responsibilities/person closely associated a) Name Analytical Bioventures S.C.A (RCS B89265) 23, Va Fleuri, L-1526 Luxembourg 2. Reason for the notification a) Position / status Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin b) Initial notification / amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Eurofins Scientific S.E.   b) LEI 529...
22.09.25 - 17:51
Eurofins Scientific SE: Weekly Report on Share Repurchases From 15th September to 19th September 2025 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 15/09/2025 FR0014000MR3 10 000 63.7208 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 16/09/2025 FR0014000MR3 10 000 62.7848 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 17/09/2025 FR0014000MR3 10 000 62.7099 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 18/09/2025 FR0014000MR3 10 000 62.3090 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 19/09/2025 FR0014000MR3 10 000 62.6369 XPAR       TOTAL 50 000 62.8323   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes Contacts ...
16.09.25 - 00:01
Protecting the Integrity of Ubiquinol --Launch of "Ubiquinol Verified Program" (PR Newswire)
 
PASADENA, Texas, Sept. 16, 2025 /PRNewswire/ - Kaneka North America LLC Nutrients Division ("Kaneka Nutrients") is pleased to announce the launch of the Ubiquinol Verified Program (https://www.eurofins.co.jp/食品分析/ユーロフィンqken/ubiquinol-verified-program/), a new initiative dedicated to......
15.09.25 - 17:51
Eurofins Scientific SE: Weekly Report on Share Repurchases from 08th September to 12th September 2025 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 09/08/2025 FR0014000MR3 10 000 62.8437 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 10/08/2025 FR0014000MR3 10 000 62.0731 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 11/08/2025 FR0014000MR3 10 000 62.8627 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/08/2025 FR0014000MR3 10 000 63.4384 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/08/2025 FR0014000MR3 10 000 64.4172 XPAR       TOTAL 50 000 63.9921   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-progra...
08.09.25 - 19:48
Eurofins Scientific SE: Weekly Report on Share Repurchases From 02nd September to 05th September 2025 (Business Wire)
 
 LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Weekly report on share repurchases from 02nd September to 05th September 2025   Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/09/2025 FR0014000MR3 10 000 62.8437 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/09/2025 FR0014000MR3 10 000 62.0731 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 04/09/2025 FR0014000MR3 10 000 62.8627 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 05/09/2025 FR0014000MR3 10 000 63.4384 XPAR       TOTAL 40 000 62.8045   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programm...
01.09.25 - 17:51
Eurofins Scientific SE: Weekly Report on Share Repurchases of 29th August 2025 (Business Wire)
 
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 29/08/2025 FR0014000MR3 10 000 64.4625 XPAR       TOTAL 10 000 64.4625   Transaction details In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes Contacts Eurofins Scientific SE...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein gelegtes Ei kann zum Findling werden. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!